anv419
Showing 1 - 3 of 3
Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,
Not yet recruiting
- Multiple Myeloma
- +4 more
- ANV419
- +2 more
- (no location specified)
Nov 29, 2022
Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or
Recruiting
- Advanced Solid Tumor
- +2 more
- ANV419
-
Barcelona, Spain
- +4 more
Dec 19, 2022
Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)
Recruiting
- Melanoma (Skin)
- +4 more
- ANV419
- +2 more
-
Bloomington, Minnesota
- +7 more
Jan 31, 2023